循環中のイリシンのレベルが,肥満に関連した動脈硬化症の臨床結果に与える影響
1Clinical Laboratory, Ningbo Zhenhai People's Hospital (Ningbo No. 7 Hospital) Ningbo, Zhejiang, China.
American journal of translational research
|February 12, 2026
まとめ
循環量が低いイリシンは,重度の動脈硬化症と肥満患者の心臓血管疾患の不良の結果と関連しています. アイリシン濃度の上昇は,主要な心血管疾患の有害事象のリスクの低下と相関しています.
科学分野:
- 心血管研究 循環器科の研究
- メタボリックシンドロームとは
- エンドクリノロジー エンドクリノロジー
背景:
- 肥満に関連した動脈硬化症は,重要な臨床的課題です.
- 代謝機能障害と心血管疾患におけるイリシンの役割を理解することは極めて重要です.
研究 の 目的:
- 循環中のイリシン濃度,代謝プロファイル,および肥満関連性動脈硬化症における臨床結果との関連性を調査する.
主な方法:
- BMIと動脈硬化状態によって階層化された220人の患者を遡及的に調査した.
- 血清アイリシン,グルコース,HbA1c,HOMA-IR,脂質プロファイル,および小密度のLDLの分析.
- エコーカルディオグラフィー,頸動脈超音波撮影,および主要な有害心血管イベント (MACE) の潜在的なフォローアップ.
主要な成果:
- イリシンの濃度は,BMIと動脈硬化症の増加とともに徐々に低下した.
- 代謝障害 (グルコース,HbA1c,HOMA-IR,脂質不全症) は,肥満や動脈硬化で悪化する.
- 重度の動脈硬化症は,低アイリシン (OR 0.128) によって強く予測されました.
- イリシンの1ng/mLの増加は,MACEリスクの26%の減少と関連していました.
結論:
- 低循環性イリシンは,重度の動脈硬化症の独立した予測因子です.
- イリシンの濃度の低下は,肥満に関連した血管疾患における有害な心血管疾患と関連しています.
関連する概念動画
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
568
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
568
Obesity
1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Atherosclerosis III: Management
442
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
442
Atherosclerosis I: Introduction
1.1K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.1K
Predicting Reaction Outcomes
11.0K
Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
11.0K
Outcomes of Glycolysis
107.7K
Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.7K


